Jane Street’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Jane Street’s Portfolio BLPH Stock Details BLPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,762	Closed	-$12.4K	–	10611
2022 Q4	$12.4K	Buy	+13,762	New	+$14.1K	﹤0.01%	8717
2022 Q2	–	Sell	-37,327	Closed	-$88K	–	11534
2022 Q1	$88K	Sell	37,327 -36,733	-50%	-$87.4K	﹤0.01%	9514
2021 Q4	$230K	Buy	+74,060	New	+$246K	﹤0.01%	8611
2018 Q4	–	Sell	-741	Closed	-$12K	–	6124
2018 Q3	$12K	Buy	+741	New	+$17.6K	﹤0.01%	4991

Other funds holding BLPH

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street's BLPH Position: Q1 2023 in Review

Jane Street sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q1 2023, closing a stake of 13,762 shares — an estimated $12.4K sold.

Jane Street first reported a position in BLPH in Q3 2018 and held it in 4 quarters. The position peaked at $230K in Q4 2021. 19 funds tracked by Wall St. Rank hold BLPH as of Q1 2023.

Jane Street reported no remaining Bellerophon Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
Jane Street sold 13,762 Bellerophon Therapeutics, Inc. shares in Q1 2023, an estimated $12.4K.
Jane Street first reported a position in Bellerophon Therapeutics, Inc. in Q3 2018 and held it in 4 quarters.
Jane Street's Bellerophon Therapeutics, Inc. position peaked at $230K in Q4 2021.
19 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.